Sign in
4

Changes in Ownership

RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-23-130499

Chief Technical Officer sold 12,941 shares at an average $50.00 ($647,114)

  • Chief Technical Officer acquired 9,200 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Shulman Joseph Chief Technical Officer 2023-12-27 Option exercise 10b5-1 +2,400 $21.38 $51,312 6,141 D
Shulman Joseph Chief Technical Officer 2023-12-27 Sale 10b5-1 −5,015 $50.01 $250,796 1,126 D
Shulman Joseph Chief Technical Officer 2023-12-28 Option exercise 10b5-1 +6,800 $21.38 $145,384 7,926 D
Shulman Joseph Chief Technical Officer 2023-12-28 Sale 10b5-1 −7,926 $50.00 $396,318 0 D
Derivatives
Shulman Joseph Chief Technical Officer 2023-12-27 Option exercise · Stock Option (Right to Buy) 10b5-1 −2,400 82,600 D
Shulman Joseph Chief Technical Officer 2023-12-28 Option exercise · Stock Option (Right to Buy) 10b5-1 −6,800 75,800 D
Open-market sales · 12,941 sh · avg $50.00 · $647,114
Loading xslF345X05/tm2333854-1_4seq1.xml…